Application of a method used to deconstruct a single dose pharmacokinetic profile from multiple dose data-Reference-Cited by-同舟云学术

Application of a method used to deconstruct a single dose pharmacokinetic profile from multiple dose data

Published:2015-04-21 Issue:6 Volume:36 Page:405-409
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Stockmann Chris¹²,Spigarelli Michael G.¹²,Healy Daniel P.³⁴,Gottschlich Michele M.⁴,Kagan Richard⁴⁵,Balch Alfred H.¹²,Sherwin Catherine¹²

Affiliation:

1. Division of Clinical Pharmacology, Department of Pediatrics; University of Utah School of Medicine; Salt Lake City Utah USA

2. Department of Pharmacology and Toxicology; University of Utah College of Pharmacy; Salt Lake City Utah USA

3. James L. Winkle College of Pharmacy; University of Cincinnati, Cincinnati, Ohio, USA; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio USA

4. Shriners Hospitals for Children; Cincinnati Ohio USA

5. Department of Surgery; University of Cincinnati; Cincinnati Ohio USA

Funder

American Foundation for Pharmaceutical Education

Shriners Hospitals for Children

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference13 articles.

1. Bioequivalence studies: single vs multiple dose;Steinijans;Int J Clin Pharmacol Ther Toxicol,1992

2. Effect of length of sampling schedule and washout interval on magnitude of drug carryover from period 1 to period 2 in two-period, two-treatment bioequivalence studies and its attendant effects on determination of bioequivalence;Dhariwal;Biopharm Drug Dispos,2003

3. Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteers;Brennan;Antimicrob Agents Chemother,2012

4. Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects;Chen;J Clin Pharmacol,2012

5. Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects;Graham;Br J Clin Pharmacol,2012